Nutex Health Inc. (NUTX) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$213.96

From 52W high−3.93%

Volume245830.00

Market cap$1.43B

P/E (TTM)8.0x

P/S (TTM)1.7x

Div yield—

Key dataSep 18, 2026

Open

$213.96

From 52W high

−3.93%

Volume

245830.00

Market cap

$1.43B

ValuationView details →

P/E (Fwd)

8.0x

EV/EBITDA

4.4x

P/E (TTM)

8.0x

RSI (14)

62.6

MomentumView details →

1D Return

−2.58%

YTD Return

+28.01%

SummaryUpdated Jun 1, 2026

Nutex Health, Inc. (NASDAQ:NUTX) is a technology-enabled healthcare services company founded in 2011 and headquartered in Houston, Texas. The company went public in April 2022 and operates through two primary divisions: a Hospital division that owns and operates 21 micro-hospitals across 8 states, and a Population Health Management division that manages provider networks and independent physician associations. Nutex has experienced dramatic financial improvement, transforming from significant losses in 2022-2023 to strong profitability in 2024, largely driven by successful arbitration of insurance reimbursement disputes under the No Surprises Act.

Ask drillr about Nutex Health Inc. →

ValuationView details →

P/E (Fwd)

8.0x

P/E (TTM)

8.0x

EV/EBITDA

4.4x

EV/Sales

2.0x

P/S (TTM)

1.7x

P/B (TTM)

3.6x

ProfitabilityView details →

Gross Margin

51.26%

Net Margin

21.25%

EBITDA Margin

45.39%

ROE (TTM)

45.63%

ROA (TTM)

18.65%

Asset Turnover

0.88x

GrowthView details →

Revenue YoY

+6.88%

EPS YoY

+174.66%

FCF YoY

+229.38%

Revenue CAGR 3Y

+58.62%

EPS CAGR 3Y

+8.80%

EBITDA YoY

+63.31%

MomentumView details →

1D Return

−2.58%

YTD Return

+28.01%

1Y Return

+119.26%

RSI (14)

62.6

vs 50D SMA

+17.44%

vs 200D SMA

+45.39%

Capital & dividendView details →

Debt/Equity

0.88x

Current Ratio

5.00x

Quick Ratio

4.96x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$9.38

EPS Surprise

89.49%

Beats (12Q)

5/12

Next Q EPS Est

$5.71

Avg Surprise (4Q)

102.65%

Rev Surprise

−1.99%

Financials snapshotView financials →

Revenue (TTM)

846.72M

Net Income (TTM)

179.92M

Op. CF (TTM)

279.62M

Next earningsNov 17, 2026 →

Latest newsMore news →

Shares of Nutex Health, AtriCure, Iovance Biotherapeutics, Centene and Concentra Group Holdings all reached 52-week highs on Monday, September 14, 2026.5d ago

The Meridian City Council unanimously rejected Nutex Health's proposal to build a 2,400-square-foot micro-hospital at the southeast corner of Eagle and Overland roads, citing the city's arterial road access requirement.9d ago

Similar companies

Omnicell, Inc.OMCL Certara, Inc.CERT Sinohealth Technology Holdings Limited02361.HK Omada HealthOMDA GoodRx Holdings, Inc.GDRX Teladoc Health, Inc.TDOC Find similar companies →

Latest newsMore news →

Shares of Nutex Health, AtriCure, Iovance Biotherapeutics, Centene and Concentra Group Holdings all reached 52-week highs on Monday, September 14, 2026.5d ago The Meridian City Council unanimously rejected Nutex Health's proposal to build a 2,400-square-foot micro-hospital at the southeast corner of Eagle and Overland roads, citing the city's arterial road access requirement.9d ago